[1] |
CHEN W, ZHENG R, BAADE PD, et al. Cancer statistics in China, 2015[J]. Ca Cancer J Clin, 2016, 66(2): 115. doi: 10.3322/caac.21338 |
[2] |
COBURN N, SEEVARATNAM R, PASZAT L, et al. Optimal management of gastric cancer: results from an inter-national RAND/UCLA expert panel[J]. Ann Surg, 2014, 259: 102. doi: 10.1097/SLA.0b013e318288dd2b |
[3] |
PAPENFUSS WA, KUKAR M, OXENBERG J, et al. Morbidity and mortality associated with gastrectomy for gastric cancer[J]. Ann Surg Oncol, 2014, 21(9): 3008. doi: 10.1245/s10434-014-3664-z |
[4] |
KOPPERT LB, LEMMENS VE, COEBERGH JW, et al. Impact of age and comorbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer[J]. Br J Surg, 2012, 99(12): 1693. doi: 10.1002/bjs.8952 |
[5] |
BALKWILL F, MANTOVANI A.Inflammation and cancer: back to Virchow?[J]. Lancet, 2001, 357(9255): 539. doi: 10.1016/S0140-6736(00)04046-0 |
[6] |
MIYAMOTO R, INAGAWA S, SANO N, et al. The neutrophil-to-lymphocyte ratio(NLR)predicts short-term and long-term outcomes in gastric cancer patients[J]. EJSO, 2018, 44(5): S0748798318302968. |
[7] |
WANG K.DIAO F, YE Z, et al. Prognostic value of systemic immune-inflammation index in patients with gastric cancer[J]. Chin J Cancer, 2017(9): 34. |
[8] |
CHEN XD, MAO CC, WU RS, et al. Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer[J]. PLoS One, 2017, 12(4): e0175074. doi: 10.1371/journal.pone.0175074 |
[9] |
LIU X, SUN X, LIU J, et al. Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer[J]. Transl Oncol, 2015, 8(4): 339. doi: 10.1016/j.tranon.2015.06.006 |
[10] |
DAVIS CJ, SOWA D, KEIM KS, et al. The use of prealbumin and creactive protein for monitoring nutrition support in adult patients receiving enteral nutrition in an urban medical center[J]. JPEN, 2012, 36(2): 197. doi: 10.1177/0148607111413896 |
[11] |
ZHOU J, HIKI N, MINE S, et al. Role of prealbumin as a powerful and simple index for predicting postoperative complications after gastric cancer surgery[J]. Ann Surg Oncol, 2017, 24(2): 510. doi: 10.1245/s10434-016-5548-x |
[12] |
YU PJ, CASSIERE HA, DELLIS SL, et al. Impact of preoperative prealbumin on outcomes after cardiac surgery[J]. JPEN, 2015, 39(7): 870. doi: 10.1177/0148607114536735 |
[13] |
SHIMURA T, SHIBATA M, GONDA K, et al. Serum transthyretin level is associated with prognosis of patients with gastric cancer[J]. J Surg Res, 2018, 227: 145. doi: 10.1016/j.jss.2018.02.035 |
[14] |
KAWAI H, OTA H.Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer[J]. World J Surg, 2012, 36(12): 2853. doi: 10.1007/s00268-012-1766-y |
[15] |
WASHINGTON K.Edition of the AJCC Cancer Staging Manual: Stomach[J]. Ann Surg Oncol, 2010, 17(12): 30779. |
[16] |
PIETRANTONIO F, DE BRAUD F, DA PRAT V, et al. A review on biomarkers for prediction of treatment outcome in gastric cancer[J]. Anticancer Res, 2013, 33(4): 1257. |
[17] |
MARUYAMA K.The general rule of JRSGC and treatment results by the rule[J]. Cancer Letters, 1989, 45(2): 155. doi: 10.1016/0304-3835(89)90159-6 |
[18] |
SHIMADA H, TAKIGUCHI NO, SODA H, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer[J]. Gastric Cancer, 2010, 13(3): 170. doi: 10.1007/s10120-010-0554-3 |
[19] |
MANTOVANI A, ALLAVENA P, SICA A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436. doi: 10.1038/nature07205 |
[20] |
BANKS RE.The acute phase protein response in patients receiving subcutaneous IL-6.[J].Clin Exp Immunol, 2010, 102(1): 217. |
[21] |
LU J, XU BB, ZHENG ZF, et al. CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase Ⅲ trial[J]. Gastric Cancer, 2019, 22(3): 536. doi: 10.1007/s10120-018-0892-0 |